Demant upgrades financial guidance again despite October's implant issues
Danish hearing giant Demant, which upgraded its financial guidance for the full year in August, has released an interim management statement covering the period year-to-date, in which the company has raised its financial expectations for 2021 in spite of having to recall cochlear implants a little over two weeks ago.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT AND DANIEL PEDERSEN
It was a wakeup call and an economic blow when hearing aid manufacturer Demant's surgical arm Oticon Medical had to recall a number of cochlear implants in addition to halting the further production of the devices in mid October.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
GN and Demant slightly increase Veteran Affairs foothold
For subscribers
.jpg&w=384&q=75)
